Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health
The loss of bone quality and/or density is a para-physiological phenomenon observed in perimenopause and postmenopause, as well as in other conditions involving ageing, inflammatory and/or autoimmune diseases, chronic drug consumption (e.g. glucocorticoids, chemotherapies, etc) and/or nutritional deficiencies [1]. Data extensively agree with the key role of calcium (Ca) and vitamin D (vitD) supplementation for the prevention of osteopenia/osteoporosis in subjects at a higher risk of fragility fractures and for the treatment of bone strength reduction in association with antiresorptive [bisphosphonates (BPs), denosumab (Dmab)] and anabolic agents [teriparatide (TPTD), i.e.
Source: Maturitas - Category: Primary Care Authors: Anna Capozzi, Giovanni Scambia, Stefano Lello Source Type: research
More News: Autoimmune Disease | Calcium | Forteo | Magnesium | Nutrition | Orthopaedics | Osteoporosis | Primary Care | Vitamin D | Vitamins | Xgeva